TESTIM SUMMARY
Testim® 1% (testosterone gel) CIII
Testim® (testosterone gel) is a clear to translucent hydroalcoholic topical gel containing 1% testosterone. Testim® provides continuous transdermal delivery of testosterone for 24 hours, following a single application to intact, clean, dry skin of the shoulders and upper arms.
Testim® is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:
-
Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone levels and gonadotropins (FSH, LH) above the normal range.
-
Hypogonadotropic hypogonadism (congenital or acquired): idiopathic gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum levels but have gonadotropins in the normal or low range.
Testim® has not been clinically evaluated in males under 18 years of age.
|
TESTIM NEWS HIGHLIGHTS
Media Articles Related to Testim (Testosterone)
Type-2 Young Diabetic Men Suffer Low Testosterone Levels Which Affects Fertility, Muscle Mass, Heart Health
Source: Endocrinology News From Medical News Today [2008.08.28]
Testosterone Key To Disease Transmission
Source: Endocrinology News From Medical News Today [2008.08.10]
Testosterone And Body Fat Are Controlled By The Same Genes
Source: Endocrinology News From Medical News Today [2008.08.06]
AUA: Low Testosterone Linked to Balanitis Xerotica Obliterans
Source: MedPage Today Dermatology [2008.05.21]
Low Testosterone Could Weaken Older Men's Bones
Source: MedicineNet estradiol Specialty [2008.01.15]
Published Studies Related to Testim (Testosterone)
Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. [2008.08]
The Effects of Growth Hormone and/or Testosterone on Whole Body Protein Kinetics and Skeletal Muscle Gene Expression in Healthy Elderly Men: A Randomized Controlled Trial. [2008.08]
Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. [2008.07]
Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. [2008.06.05]
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. [2008.06]
Clinical Trials Related to Testim (Testosterone)
A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone [Active, not recruiting]
Oral Androgens in Man-4: (Short Title: Oral T-4) [Completed]
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride [Completed]
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes [Completed]
Study of The Effects of Testosterone in Frail Elderly Men [Completed]
|
